Immune-mediated hemolytic anemia and ITP (Proceedings)

ADVERTISEMENT

Immune-mediated hemolytic anemia and ITP (Proceedings)

source-image
Aug 01, 2008

Immune-Mediated Hemolytic Anemia

Etiology And Pathophysiology

The cause of IMHA has been discussed at length. Genetics are involved as there are breed predispositions such as the Cocker Spaniel. In addition gender may also play a role. The reason why a predisposition exists are to date unclear, though they may have something to do with red blood cell antigens or the way the immune system works. Various triggers are also thought to play a role. Vaccination has also been incriminated. In one paper 25% of dogs had been vaccinated within the last month before presentation. In several other papers an association has not been seen. Certainly in my research such a link could not be made. Drug administration and infections may also play a role. The majority of cases are idiopathic.

Once the process has been initiated, red cells are tagged for destruction by the binding of immunoglobulins or complement. Depending upon how tagged, the RBCs will be destroyed either intravascularly or extravascularly. The sites of red cell removal include liver, spleen and bone marrow. The autoantibodies can be directed at very early RBCs such as reticulocytes causing an anemia that appears non-regenerative as the precursors are removed first.

Diagnosis

Diagnosis with IMHA can proceed along the name of the disease. All components of the name, that is "immune-mediated" "hemolytic" and "anemia" need to be satisfied for a definitive diagnosis. Anemia is usually the easiest part to determine. At times one or the other areas will be present without being able to satisfy the others. This is the case when a positive Coombs test is present in an animal without anemia. This does not diagnose IMHA, in fact it may be a marker for neoplasia.

There are a variety of ways to determine that an anemia is immune-mediated. One way is a positive Coombs test, unfortunately both false positive and false negative results occur. The Coombs test identifies bound immunoglobulins or complement on the RBCs. Some types of antibodies will be picked up better than others and at times processing of the RBCs wash the antibodies off. Overall it still is a very good test. The presence of autoagglutination is definitive for IMHA. It must be differentiated from Rouleaux formation by diluting 1 drop of blood with several drops of saline. If gross agglutination is not seen, look at the slide under a microscope for aggregates of clumped RBCs. The presence of a large number of spherocytes is also a strong indicator of IMHA (pieces of the RBC membrane have been removed, leaving more hemoglobin behind in a smaller RBC).

Hemolysis must also be present to confirm IMHA. Spherocytes are a sign of both immune-mediated destruction as well as hemolysis. Icterus is if present can indicate hemolysis, though the degree of jaundice will depend upon the rapidity of hemolysis as well as possible damage to the liver (hypoxia through anemia, thrombi). Hemoglobinuria is also a strong indicator of hemolysis if urinary tract disease has been ruled out. Hemolysis determined on a blood draw is however very easy to induce, even in normal animals so it has be interpreted carefully.

It is important to remember that all the various areas must be present to have a definitive diagnosis of IMHA. Hemolysis can occur through mechanisms that are not immune mediated. Anemia can be caused by many problems. Unfortunately in some cases all the pieces of the puzzle will not fit together and the diagnosis will merely be presumptive. A definitive diagnosis does allow a very aggressive treatment approach. If not definitive, frequent reassessment is indicated to make sure another disease process has not been overlooked.

Clinical Findings

Clinical signs will depend predominantly on how anemic the animal is and how rapidly it got to the reduced PCV. If given time, animals can adapt to relatively severe anemias, on the other hand rapid progression usually makes the animal more symptomatic. Because a large part of the body is being attacked a very vigorous immune response is occurring with the liberation of many cytokines and inflammatory mediators. These cause many of the severe systemic signs seen with IMHA such as dever, lethargy, and anorexia.In most cases the mucous membranes will be pale and jaundiced. Often liver and splenic enlargement is palpated in these patients. Concurrent ITP (IMHA and ITP together are called Evan's Syndrome) can also contribute clinical signs such as petechia, melena and hematuria. Discoloration of the urine is common either through blood, hemoglobin or bilirubin.